Meril Life Sciences India Private Limited, a active private limited company, was established on 02 June 1999 in Vapi, Gujarat, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U33110GJ1999PTC060787. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹62.10 Cr and a paid-up capital of ₹6.06 Cr.
Formerly known as Interventional Technologies Limited, Interventional Technologies Private Limited. It upholds a compliant status. Its leadership includes Pramodkumar Minocha (Director), Sanjay Prafullabhai Shah (Whole-Time Director). Past directors included Tarak Dineshkumar Buch, Vinaykumar Navnitrai Pandya, Mustufa Makwana. It holds ₹202.35 Cr open charges and ₹24.47 Cr settled loans. Its latest AGM occurred on 16 August 2025, with the balance sheet filed on 31 March 2025. It is based at Bilakhia House, Survey No. 135/139, Muktanand Marg, Chala,, Vapi, Gujarat, 396191.
U33110GJ1999PTC060787
060787
02 June 1999
₹62.10 Cr
₹6.06 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Meril Life Sciences India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pramodkumar Minocha | Director | 01 Sep 2006 | Current |
| Sanjay Prafullabhai Shah | Whole-Time Director | 13 Jul 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 12 Oct 2013 | Past |
| Pramod Abcsdd | Director | 25 Jan 2010 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Company Secretary | 07 Mar 2020 | Past |
| Pramod Abcsdd | Managing Director | 22 Oct 2009 | Past |
| Pramod Abcsdd | Director | 13 Jul 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Meril Life Sciences India Private Limited, for the financial year ended 2025, experienced significant growth in revenue, with a 31.43% increase. The company also saw a substantial improvement in profitability, with a 63.88% increase in profit. The company's net worth Soared by an impressive increase of 42.05%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Meril Life Sciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,023,500,000.00
₹244,688,500.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jun 2019 | Hdfc Bank Limited | ₹20.00 Cr | Open |
| 24 Jul 2014 | Others | ₹105.00 Cr | Open |
| 11 Jun 2014 | Dbs Bank Ltd | ₹20.00 Cr | Open |
| 12 Dec 2013 | Axis Bank Limited | ₹37.35 Cr | Open |
| 20 Feb 2013 | Yes Bank Limited | ₹20.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Meril Life Sciences India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Meril Life Sciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meril Life Sciences India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Meril Life Sciences India Private Limited last Annual general meeting of members was held on 16 Aug 2025 as per latest MCA records. was completed.
Meril Life Sciences India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
Progress on A charge with Others of Rs. 105.00 Cr registered on 24 Jul 2014 with Charge ID 10515362 was modified on 16 Feb 2024. was documented.
The activity Rushi Jagdish Sathe was appointed as a Company Secretary was appointed as a Company Secretary on 01 Jun 2023 & has been associated with this company since 2 years 7 months . was completed.
The activity A charge with Axis Bank Limited of Rs. 37.35 Cr registered on 12 Dec 2013 with Charge ID 10468803 was modified on 29 Dec 2020. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 20.00 Cr with Charge ID 100273446 was registered on 25 Jun 2019. was recorded as a recent event.
Panel to decide if Sun Pharma’s anti-cancer drug, Meril’s biodegradable stent have therapeutic advantage.Mumbai-based Sun Pharmaceuticals is seeking an exemption for its anti-cancer gemcitabine hydrochloride injection.
Meril has developed MeRes100, which it claims is the country's first locally made bioresorbable vascular scaffold, or naturally dissolving stent for clearing blockages in arteries.
The CIN of Meril Life Sciences India Private Limited is U33110GJ1999PTC060787.
Meril Life Sciences India Private Limited is headquartered at Bilakhia House, Survey No. 135/139, Muktanand Marg, Chala,, Vapi, Gujarat, 396191.
Meril Life Sciences India Private Limited was incorporated on 02 June 1999.
The current directors of Meril Life Sciences India Private Limited are
The primary industry of Meril Life Sciences India Private Limited is Trade.
Meril Life Sciences India Private Limited is unlisted.
The authorized capital of Meril Life Sciences India Private Limited is ₹62.10 Cr, and the paid-up capital is ₹6.06 Cr.
The compliance status of Meril Life Sciences India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX